The automated Quantcha Trade Ideas Service has detected a promising Long Risk Reversal trade opportunity for INNOVATE BIOPHARMACEUTICALS INC. COMMON STOCK (INNT) for the 17-Aug-2018 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine.
INNT was recently trading at $22.50 and has an implied volatility of 48.87% for this period. Based on an analysis of the options available for INNT expiring on 17-Aug-2018, there is a 34.13% likelihood that the underlying will close within the analyzed range of $22.75-$39.17 at expiration. In this scenario, the average linear return for the trade would be 227.94%.
Big 10.13% Change: After closing the last trading session at $20.43, INNOVATE BIOPHARMACEUTICALS INC. COMMON STOCK opened today at $20.03 and has reached a high of $22.72.
Trade approach: A movement as big as 10.13% is a significantly bullish indicator, so this trade is designed to be profitable if INNT maintains its current direction and does not revert back to pricing on the bearish side of $22.50 on 17-Aug-2018. If possible, the trade has been padded such that slight movement against the trade would still return a profit.
Upside potential: Using this bullish strategy, the trade would be profitable if INNOVATE BIOPHARMACEUTICALS INC. COMMON STOCK closes at or above $17.35 on 17-Aug-2018. Based on our risk-neutral analysis, there is a 69.10% likelihood of this return.
Downside risk: As with any options trade, there is a substantial downside risk where you may lose most or all of your investment.
To analyze this trade in depth, please visit the Quantcha Options Search Engine.
This is an automated post generated based on a market analysis of delayed data at 7/9/2018 10:56:16 AM ET. The analysis does not include brokerage fees or commissions and is not investment advice.